December #192 : FDA OKs First Rapid Test for Acute HIV - by Benjamin Ryan

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

Features

The POZ 100: Celebrating Unsung Heroes

The POZ 100: A-C

The POZ 100: D-F

The POZ 100: G-H

The POZ 100: J-L

The POZ 100: M-O

The POZ 100: P-R

The POZ 100: S-T

The POZ 100: V-Z

Positive Networks

From the Editor

Your Song

Feedback

Letters-December 2013

The POZ Q+A

Fire in the Blood

POZ Planet

Law of Desire

Do Some Men Want to Get AIDS?

Rocky Road

Public Knowledge

First in the Fight

Remembrance of Things Past

That ’80s Show

Say What? Lee Daniels Edition

Voices

Remembering J.C. Suares

Care and Treatment

Now Available: New Integrase Inhibitor

‘Quad’ as Effective as Older Options, Fewer Side Effects

Does HIV Make Addiction More Insidious?

TB Preventative Therapy Lowers Deaths by One Third

FDA OKs First Rapid Test for Acute HIV

GMHC Treatment Issues December 2013

Research Notes

Prevention: Malaria Vaccine Shows Promise

Treatment: Soybean Compound May Fight HIV

Cure: Drug-Free Viral Control in Monkeys

Concerns: Lymphoma Survival Unimproved

POZ Survey Says

Your Voice

POZ Heroes

A Mother’s Love

   
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

December 2013

FDA OKs First Rapid Test for Acute HIV

by Benjamin Ryan

The U.S. Food and Drug Administration (FDA) has announced its approval of the first rapid HIV test that can, with a finger prick, detect both HIV-1 and HIV-2 antibodies as well as a key antigen that indicates a recent infection with HIV-1. Results take just 20 minutes and have an accuracy of greater than 99 percent.

“It’s going to be a game changer for prevention,” says Cynthia Tucker, director of prevention and community partnerships at AIDS Foundation of Chicago (AFC), “because it will allow us to tell individuals at an earlier time that they’re HIV positive.” She says AFC is eager to adopt the test when it becomes available.

Because the HIV-1 p24 antigen appears 12 to 26 days after infection, which on average is five to seven days earlier than HIV antibodies, the Alere Determine HIV-1/2 Ag/Ab Combo assay can accurately diagnose certain early cases of HIV that would otherwise produce a false negative result with a standard antibody test. Thus, testing with Alere will narrow the notorious “window period,” which calls into question a test’s accuracy when someone has had recent potential exposures to HIV. The antigen test can also detect an acute, or very recent, infection.

With minimal training, outreach workers can use the easily portable test among populations who might not have access to testing in a traditional health care environment.

Search: rapid test, testing, FDA

Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    CuteBoyinQns
    Jackson Heights
    New York


    oceanblue65
    louisiana
    Louisiana


    Sexynyrican
    Brooklyn
    New York


    pozsmith1
    East Bay
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.